15.48

3.13% 0.47

After Hours: 15.48

10 X Genomics Inc (TXG)

Overview News Price History Option Chain Financials Discussions Forecast

10 X Genomics Inc stock is traded at $15.48, with a volume of 1.48M. It is up +3.13% in the last 24 hours and down -0.06% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Previous Close:

$15.01

Open:

$15.28

24h Volume:

1.48M

Relative Volume:

0.78

Market Cap:

$1.88B

Revenue:

$631.73M

Net Income/Loss:

$-239.78M

P/E Ratio:

-8.1047

EPS:

-1.91

Net Cash Flow:

$-33.45M

1W Performance:

+16.22%

1M Performance:

-0.06%

6M Performance:

-31.47%

1Y Performance:

-63.76%

1-Day Range:

$15.22

$15.72

1-Week Range:

$12.98

$15.72

52-Week Range:

$12.95

$57.90

10 X Genomics Inc Stock (TXG) Company Profile

Name

10 X Genomics Inc

Sector

Healthcare (1200)

Industry

Health Information Services (60)

Phone

(925) 401-7300

Address

6230 STONERIDGE MALL ROAD, PLEASANTON, CA

Employee

1,259

Twitter

@10xgenomics

Next Earnings Date

2024-10-31

Latest SEC Filings

TXG's Discussions on Twitter

Compare TXG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TXG 10 X Genomics Inc	15.48	1.88B	631.73M	-239.78M	-33.45M	-1.91
VEEV Veeva Systems Inc	226.76	36.93B	2.57B	615.26M	996.76M	3.32
SOLV Solventum Corp	72.48	12.43B	8.26B	66.00M	1.17B	0.00
TEM Tempus Ai Inc	62.98	10.01B	640.44M	-743.28M	-206.93M	0.00
DOCS Doximity Inc	53.39	9.94B	493.63M	160.55M	162.20M	0.55
HQY Healthequity Inc	102.47	8.91B	1.10B	105.67M	-197.98M	0.1475

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-24	Initiated	Leerink Partners	Outperform
Jul-22-24	Upgrade	Jefferies	Hold → Buy
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold
May-01-24	Downgrade	TD Cowen	Buy → Hold
Dec-14-23	Initiated	Guggenheim	Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-05-23	Resumed	JP Morgan	Overweight
May-10-23	Initiated	Barclays	Overweight
Mar-31-23	Initiated	Stephens	Overweight
Feb-02-23	Initiated	UBS	Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Aug-18-22	Downgrade	Goldman	Neutral → Sell
Jul-25-22	Initiated	Canaccord Genuity	Buy
Jul-15-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform
Oct-15-21	Resumed	Cowen	Outperform
Sep-14-21	Downgrade	BofA Securities	Buy → Neutral
Mar-15-21	Initiated	William Blair	Outperform
Dec-02-20	Initiated	Goldman	Neutral
Sep-09-20	Initiated	Morgan Stanley	Overweight
Jul-10-20	Initiated	Stifel	Buy
Mar-05-20	Initiated	Guggenheim	Buy
Jan-07-20	Initiated	Citigroup	Buy
Oct-07-19	Initiated	BofA/Merrill	Buy
Oct-07-19	Initiated	Cowen	Outperform
Oct-07-19	Initiated	JP Morgan	Overweight
Sep-24-19	Initiated	Evercore ISI	Outperform

View All

10 X Genomics Inc Stock (TXG) Latest News

Nov 26, 2024

TXG (10x Genomics) 6-1 Month Momentum % : -31.43% (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

TXG (10x Genomics) Effect of Exchange Rate Changes : $0.2 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 25, 2024

10x genomics CEO Serge Saxonov sells $91,612 in stock - Investing.com India

Nov 25, 2024

10x genomics chief scientific officer sells $79,485 in stock By Investing.com - Investing.com South Africa

Nov 25, 2024

10x Genomics (LTS:0A88) Operating Cash Flow per Share : $0.33 (TTM As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

10x genomics CEO Serge Saxonov sells $91,612 in stock By Investing.com - Investing.com South Africa

Nov 25, 2024

10x genomics chief scientific officer sells $79,485 in stock - Investing.com

Nov 25, 2024

TXG (10x Genomics) Net Intangibles Purchase And Sale : $-1.0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 24, 2024

Algert Global LLC Acquires 252,994 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 24, 2024

Nov 23, 2024

10x Genomics to Present at the Wolfe Research 2024 Healthcare Co - GuruFocus.com

Nov 23, 2024

Primecap Management Co. CA Buys 108,600 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Nov 23, 2024

Nov 22, 2024